Artivion (AORT) Revenue Growth (1y) (2011 - 2026)
Artivion (AORT) Revenue Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.43 Bn | 193.83 Bn | 7.27 Bn | 13.02% |
| 2 | Stryker | 126.52 Bn | 123.04 Bn | 4.50 Bn | 9.42% |
| 3 | Medtronic | 118.76 Bn | 109.54 Bn | 6.41 Bn | 9.86% |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | 7.53% |
| 5 | Edwards Lifesciences | 52.20 Bn | 47.95 Bn | 1.35 Bn | 13.63% |
| 6 | Dexcom | 34.51 Bn | 32.56 Bn | 830.00 Mn | 13.08% |
| 7 | GE HealthCare Technologies | 33.75 Bn | 31.65 Bn | 2.18 Bn | 5.75% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 95.64% |
| 9 | Steris | 23.09 Bn | 22.61 Bn | 684.20 Mn | 7.30% |
| 10 | Artivion | 1.36 Bn | 1.29 Bn | 80.52 Mn | 11.32% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.32% |
| Mar 31, 2026 | 17.54% |
| Dec 31, 2025 | 19.20% |
| Sep 30, 2025 | 18.39% |
| Jun 30, 2025 | 15.26% |
| Mar 31, 2025 | 1.59% |
| Dec 31, 2024 | 3.88% |
| Sep 30, 2024 | 9.02% |
| Jun 30, 2024 | 9.82% |
| Mar 31, 2024 | 17.06% |
| Dec 31, 2023 | 17.98% |
| Sep 30, 2023 | 14.34% |
| Jun 30, 2023 | 11.09% |
| Mar 31, 2023 | 7.79% |
| Dec 31, 2022 | 0.01% |
| Sep 30, 2022 | 6.41% |
| Jun 30, 2022 | 5.51% |
| Mar 31, 2022 | 8.62% |
| Dec 31, 2021 | 16.93% |
| Sep 30, 2021 | 10.86% |